Q
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
Price:
0.75 USD
-1.97%
Updated:
May 21, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of QNRX.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
QNRX
Relative Value
Base Case
Not Available
Q
Valuation Multiples
Multiples Across Competitors
QNRX Competitors Multiples
Quoin Pharmaceuticals Ltd Competitors
Quoin Pharmaceuticals Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IL |
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
2.9m USD | 0 | -0.3 | 0.9 | 0.9 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
225B USD | 5.3 | 37.3 | 23.2 | 33.9 | |
| US |
|
Danaher Corp
NYSE:DHR
|
197.2B USD | 4.5 | 24.5 | 17.7 | 21.8 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
44.9B USD | 6.7 | 36.4 | 29 | 34.9 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37B CHF | 5.5 | 56.5 | 19.4 | 28.5 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
41.4B USD | 2.8 | 30.5 | 16.6 | 25.6 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
55.4T KRW | 15 | 64.6 | 34.1 | 49.1 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
32B USD | 8.5 | 41.3 | 28.1 | 31.2 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
26.3B USD | 3.2 | 38.5 | 17.4 | 26.7 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
24.9B USD | 8.5 | 43.8 | 30.4 | 36.9 | |
| US |
|
Waters Corp
NYSE:WAT
|
20.9B USD | 7.2 | 34.6 | 23.2 | 28.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
